Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KLHL21 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | multiple interactions | ISO | Klhl21 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLHL21 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Estradiol affects the expression of KLHL21 mRNA | CTD | PMID:22574217 | 17beta-estradiol | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Estradiol results in increased expression of KLHL21 mRNA | CTD | PMID:23019147 and PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Klhl21 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to KLHL21 promoter] | CTD | PMID:19654925 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Klhl21 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of KLHL21 mRNA | CTD | PMID:21570461 | acrolein | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KLHL21 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KLHL21 mRNA | CTD | PMID:32699268 | acrylamide | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of KLHL21 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of KLHL21 mRNA | CTD | PMID:22100608 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of KLHL21 mRNA | CTD | PMID:33354967 | alpha-pinene | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KLHL21 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KLHL21 mRNA | CTD | PMID:32699268 | aristolochic acid A | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of KLHL21 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | KLHL21 (Homo sapiens) | 6480464 | Arsenic affects the methylation of KLHL21 gene | CTD | PMID:25304211 | arsane | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA | CTD | PMID:32525701 | arsenic atom | affects methylation | ISO | KLHL21 (Homo sapiens) | 6480464 | Arsenic affects the methylation of KLHL21 gene | CTD | PMID:25304211 | arsenic atom | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA | CTD | PMID:32525701 | arsenous acid | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of KLHL21 mRNA | CTD | PMID:27829220 | benzo[a]pyrene | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of KLHL21 mRNA | CTD | PMID:21569818 and PMID:22228805 | benzo[a]pyrene | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of KLHL21 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene diol epoxide I | decreases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of KLHL21 mRNA | CTD | PMID:27178563 and PMID:34947998 | bisphenol A | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | bisphenol A results in increased expression of KLHL21 mRNA | CTD | PMID:33221593 | bisphenol A | affects expression | ISO | KLHL21 (Homo sapiens) | 6480464 | bisphenol A affects the expression of KLHL21 mRNA | CTD | PMID:30903817 | bisphenol A | decreases methylation | ISO | Klhl21 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of KLHL21 promoter | CTD | PMID:27312807 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of KLHL21 mRNA | CTD | PMID:25181051 | bisphenol F | decreases methylation | ISO | KLHL21 (Homo sapiens) | 6480464 | bisphenol F results in decreased methylation of KLHL21 gene | CTD | PMID:31601247 | butan-1-ol | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KLHL21 mRNA | CTD | PMID:29432896 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of KLHL21 mRNA | CTD | PMID:19167457 | captan | decreases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Captan results in decreased expression of KLHL21 mRNA | CTD | PMID:31558096 | carbon nanotube | decreases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | ciguatoxin CTX1B | affects expression | ISO | Klhl21 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of KLHL21 mRNA | CTD | PMID:18353800 | cisplatin | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of KLHL21 mRNA | CTD | PMID:21858171 | clofibrate | decreases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of KLHL21 mRNA | CTD | PMID:17585979 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of KLHL21 mRNA | CTD | PMID:24386269 | cobalt dichloride | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of KLHL21 mRNA | CTD | PMID:19320972 | copper(II) sulfate | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of KLHL21 mRNA | CTD | PMID:19549813 | curcumin | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Curcumin results in increased expression of KLHL21 mRNA | CTD | PMID:17198877 | cyclosporin A | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of KLHL21 mRNA | CTD | PMID:20106945 and PMID:25562108 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of KLHL21 mRNA | CTD | PMID:23640034 | diarsenic trioxide | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of KLHL21 mRNA | CTD | PMID:27829220 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of KLHL21 mRNA | CTD | PMID:25152437 | dorsomorphin | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of KLHL21 mRNA | CTD | PMID:29391264 | epoxiconazole | decreases expression | ISO | Klhl21 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of KLHL21 mRNA | CTD | PMID:35436446 | fenthion | decreases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Fenthion results in decreased expression of KLHL21 mRNA | CTD | PMID:34813904 | fluoranthene | multiple interactions | ISO | Klhl21 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of KLHL21 mRNA | CTD | PMID:28329830 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of KLHL21 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Klhl21 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLHL21 mRNA | CTD | PMID:22206623 | folic acid | decreases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of KLHL21 mRNA | CTD | PMID:25629700 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of KLHL21 mRNA | CTD | PMID:33387578 | hexane | decreases methylation | EXP | | 6480464 | n-hexane results in decreased methylation of KLHL21 promoter | CTD | PMID:23740543 | hydrogen peroxide | affects expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of KLHL21 mRNA | CTD | PMID:20044591 | leflunomide | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | leflunomide results in increased expression of KLHL21 mRNA | CTD | PMID:28988120 | Licochalcone B | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | licochalcone B results in increased expression of KLHL21 mRNA | CTD | PMID:33647349 | lipopolysaccharide | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of KLHL21 mRNA | CTD | PMID:35811015 | mercury dibromide | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA | CTD | PMID:27188386 | methamphetamine | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of KLHL21 mRNA | CTD | PMID:36914120 | methidathion | affects expression | ISO | Klhl21 (Mus musculus) | 6480464 | methidathion affects the expression of KLHL21 mRNA | CTD | PMID:34813904 | methotrexate | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of KLHL21 mRNA | CTD | PMID:24657277 | methyl methanesulfonate | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of KLHL21 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of KLHL21 mRNA | CTD | PMID:28001369 | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of KLHL21 mRNA | CTD | PMID:23665939 | ozone | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KLHL21 mRNA more ... | CTD | PMID:32699268 and PMID:35430440 | p-chloromercuribenzoic acid | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | Klhl21 (Mus musculus) | 6480464 | Acetaminophen affects the expression of KLHL21 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of KLHL21 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of KLHL21 mRNA | CTD | PMID:21420995 and PMID:22230336 | parathion | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Parathion results in increased expression of KLHL21 mRNA | CTD | PMID:34813904 | perfluorooctanoic acid | decreases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of KLHL21 mRNA | CTD | PMID:36326898 | phenobarbital | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of KLHL21 mRNA | CTD | PMID:19270015 | phenobarbital | affects expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of KLHL21 mRNA | CTD | PMID:19159669 | phenylmercury acetate | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of KLHL21 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA | CTD | PMID:27188386 | piroxicam | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [Piroxicam co-treated with Cisplatin] results in decreased expression of KLHL21 mRNA | CTD | PMID:21858171 | potassium chromate | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of KLHL21 mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of KLHL21 mRNA | CTD | PMID:22079256 | quercetin | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Quercetin results in increased expression of KLHL21 mRNA | CTD | PMID:21632981 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of KLHL21 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of KLHL21 mRNA | CTD | PMID:25895662 | silver atom | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Silver results in increased expression of KLHL21 mRNA | CTD | PMID:27131904 | silver atom | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Silver results in increased expression of KLHL21 mRNA | CTD | PMID:26014281 | silver(0) | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Silver results in increased expression of KLHL21 mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Silver results in increased expression of KLHL21 mRNA | CTD | PMID:26014281 | sodium arsenate | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of KLHL21 mRNA | CTD | PMID:32525701 | sodium arsenite | affects methylation | ISO | KLHL21 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of KLHL21 gene | CTD | PMID:28589171 | sodium arsenite | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of KLHL21 mRNA | CTD | PMID:36209798 | sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of KLHL21 mRNA | CTD | PMID:22110744 | sodium dichromate | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | sodium bichromate results in increased expression of KLHL21 mRNA | CTD | PMID:17685462 | sodium dodecyl sulfate | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of KLHL21 mRNA | CTD | PMID:31734321 | sulforaphane | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of KLHL21 mRNA | CTD | PMID:31838189 | sulindac sulfide | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | sulindac sulfide results in increased expression of KLHL21 mRNA | CTD | PMID:16184548 | tetrachloromethane | increases expression | ISO | Klhl21 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of KLHL21 mRNA | CTD | PMID:31919559 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of KLHL21 mRNA | CTD | PMID:34492290 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of KLHL21 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of KLHL21 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA | CTD | PMID:27188386 | troglitazone | decreases expression | ISO | Klhl21 (Mus musculus) | 6480464 | troglitazone results in decreased expression of KLHL21 mRNA | CTD | PMID:28973697 | urethane | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Urethane results in increased expression of KLHL21 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of KLHL21 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | KLHL21 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of KLHL21 mRNA | CTD | PMID:26272509 | zinc atom | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of KLHL21 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | KLHL21 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of KLHL21 mRNA | CTD | PMID:18593933 | |